8-K current report · filed Oct 26, 2026

Surgery Partners, Inc. (SGRY) 8-K Current Report: October 26, 2026

Item 1.01Item EX-99.1Item 7.01SGRY overview

Short answer

Surgery Partners, Inc. (SGRY) filed an 8-K current report with the SEC on October 26, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). Surgery Partners agreed to be acquired for $23.50 cash per share, making the transaction the key near-term valuation driver.

Surgery Partners, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Surgery Partners agreed to be acquired for $23.50 cash per share, making the transaction the key near-term valuation driver
  • Reinvestment Stockholders will roll their shares into Parent equity and support approval, aligning existing holders with the buyer
  • Closing requires majority stockholder approval, disinterested-stockholder approval, HSR clearance and no prohibitive legal restraints
  • No financing condition protects deal certainty, while Guarantor backs Parent and Merger Subsidiary obligations
  • $108,986,842 termination fee and July 23, 2027 End Date create meaningful deal-completion and break-fee considerations

Item 7.01 · Regulation FD Disclosure

  • Joint press release announces Surgery Partners’ entry into a merger agreement with HealthSpan Partners affiliate
  • Merger announcement is the key investor event, with transaction terms detailed in Exhibit 99.1

Item EX-99.1 · Exhibit EX-99.1

  • HealthSpan Partners to acquire Surgery Partners for approximately $5.7B enterprise value, making SGRY a privately held company
  • Non-Bain shareholders receive $23.50 cash per share, while Bain affiliates roll over holdings into the acquiring entity
  • Bain owns approximately 39% and agreed to support the transaction, reducing shareholder-approval uncertainty
  • Closing targeted for Q1 2027, subject to shareholder and regulatory approvals
  • Surgery Partners’ Nasdaq listing ends after closing, with operations, brand and headquarters expected to remain in place

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Surgery Partners, Inc. 8-K filings

Get the next SGRY 8-K as it lands

Follow SGRY for push alerts, or ask the research agent what this filing means.